Millennium Management LLC 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-16 4:18 pm Sale | 2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Millennium Management LLC | 1,664,317 1.000% | -6,604,499 (-79.87%) | Filing |
| 2023-06-16 4:04 pm Purchase | 2023-06-09 | 13G | X4 Pharmaceuticals, Inc. XFOR | Millennium Management LLC | 8,268,816 5.200% | 8,268,816 (New Position) | Filing |